If you've ever found an insulin that just works—one that gives you flexibility through puberty, pregnancy, or perimenopause—imagine having it pulled from the shelves.
That’s exactly what’s happening with Levemir (insulin detemir) in the U.S., and soon, around the world.
In this episode, I’m joined by Alison Smart, President of the Alliance to Protect Insulin Choice. Alison’s daughter was diagnosed with type 1 diabetes at age 13, and Levemir became the insulin that allowed her to stay active, stable, and in control—especially as a teen athlete.
We talk about:
· Why Levemir’s shorter duration gives it unique flexibility
· How hormonal shifts—especially during perimenopause or pregnancy—make this insulin essential
· The real reason Levemir is being phased out (spoiler: it has nothing to do with safety or effectiveness)
· What the Alliance is doing to protect access and create a biosimilar option
· Why limiting our insulin options is a dangerous step backwards in diabetes care
Whether you're using a pump or injections, are newly diagnosed or decades in—this conversation is for anyone who believes patients deserve options.
🔗 Links mentioned in the episode:
· Learn more & support the mission: https://chng.it/qLqYjqhcLv
· https://alliancetoprotectinsulinchoice.org
· Follow on social:
X: @insulinchoice
IG: @alliancetoprotectinsulinchoice
Facebook
Hit the subscribe button and rate and review to help this podcast reach more people. Be sure to share this episode.
What to do now:
*Join the book pre-launch list for early access, bonuses, and 2026 launch updates. Grab my free guide, HRT and Type 1 Diabetes Everything I wish I knew in perimenopause.
*Follow me IG @Type1.in.midlife stay in the loop on upcoming episodes. DM me with any feedback or suggestions on topics you'd like us to cover.
Disclaimer: Nothing you hear on this Type 1 in Midlife Podcast should be a substitute for professional medical advice. Please always consult your medical professional before changing your diet, insulin dosages or health care plan.
